The cell culture consumables and equipment market size is expected to see rapid growth in the next few years. It will grow to $25.49 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to advancement in bioreactors and automated incubators, increasing investment in stem cell and gene therapy research, growth of biotechnology and pharmaceutical industries, adoption of high-throughput screening technologies, integration of smart and automated laboratory equipment. Major trends in the forecast period include rising demand for advanced cell culture consumables, expansion of stem cell and regenerative medicine research, increasing adoption of automated cell culture instruments, growth in drug screening and development applications, focus on high-quality culture media and reagents.
Increased funding for cancer research is anticipated to support the expansion of the cell culture consumables and equipment market going forward. Funding refers to the allocation of financial resources to support research, development, and innovation initiatives. Adequate funding plays a crucial role in advancing cell culture technologies and improving the availability and performance of consumables and equipment used in cancer research. For example, in September 2023, the National Cancer Institute, a US-based government agency, received a budget allocation of $7.3 billion from the United States Congress for fiscal year 2023, reflecting a $408 million increase compared to 2022. Consequently, increased funding for cancer research is reinforcing growth across the cell culture consumables and equipment market.
Leading companies operating in the cell culture consumables and equipment market are focusing on developing innovative products, such as in-unit dry hydrogen peroxide fogging sterilization, to significantly reduce contamination risk and downtime in GMP cell culture production. Dry H₂O₂ fogging sterilization is a vapor-phase decontamination method that delivers effective sterilization without condensation or water pooling. For example, in March 2025, Caron Scientific, a US-based provider of controlled-environment incubators and bioprocess equipment, launched its 7406 Series Incubator Shaker. The system offers high single-chamber capacity within a compact vertical footprint and provides precise control of temperature, CO₂, humidity, and shaking parameters. Its integrated dry H₂O₂ decontamination cycle prevents condensation and allows immediate reuse after sterilization, improving operational efficiency and contamination control in high-throughput GMP-compliant biologics production.
In June 2025, STEMCELL Technologies, a Canada-based provider of cell culture media, cell separation technologies, instruments, and contract assay services, acquired Cellular Highways Ltd. for an undisclosed amount. Through this acquisition, STEMCELL aims to strengthen its cell therapy and research instrumentation portfolio by integrating a gentle, high-speed, GMP-ready cell-sorting technology. Cellular Highways Ltd. is a UK-based biotechnology company that develops advanced cell-sorting solutions for fragile cells used in cell and gene therapy, drug discovery, and fundamental cell research.
Major companies operating in the cell culture consumables and equipment market are Becton Dickinson and Company, Corning Inc., Danaher Corporation, Eppendorf AG, HiMedia Laboratories Private Limited, Lonza Group AG, Merck KGAA, Promocell GmbH, Sartorius AG, Thermo Fisher Scientific Inc., Irvine Scientific Sales Company Inc., CellGenix GmbH, InVitria Inc., Cytiva, Bio-Techne Corporation, GenScript Biotech Corporation, Gedeon Richter Plc., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Bio-Rad Laboratories Inc., Illumina Inc., Qiagen NV, F. Hoffmann-La Roche Ltd, Norgen Biotek Corporation, Tecan Group Ltd.
North America was the largest region in the cell culture consumables and equipment market in 2025. Western Europe was the second-largest region in the global cell culture consumables and equipment market share. The regions covered in the cell culture consumables and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell culture consumables and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the cell culture consumables and equipment market by increasing costs for imported instruments such as bioreactors, incubators, and high-quality consumables like culture media and reagents. Segments like advanced cell culture instruments and high-grade reagents are most impacted, particularly in Asia-Pacific regions including China and India. This has led to higher production and operational costs, but tariffs also encourage domestic manufacturing, innovation in consumables, and investment in local laboratory infrastructure.
The cell culture consumables and equipment market research report is one of a series of new reports that provides cell culture consumables and equipment market statistics, including cell culture consumables and equipment industry global market size, regional shares, competitors with a cell culture consumables and equipment market share, detailed cell culture consumables and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture consumables and equipment industry. This cell culture consumables and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cell culture consumables and equipment are designed to support scientists in growing cells in culture media for applications such as drug discovery, tissue engineering, gene therapy, vaccine production, and toxicity testing.
The main products in cell culture consumables and equipment include consumables and instruments. Cell culture instruments comprise equipment required to support cell growth and maintenance in laboratory environments. The instruments include cell culture vessels, bioreactors, biosafety cabinets, carbon dioxide incubators, and centrifuges, while consumables include media, sera, and reagents. The applications include vaccination development, toxicity testing, cancer research, drug screening and development, recombinant product manufacturing, stem cell technologies, regenerative medicine, and others, and are used by end users such as industrial, biotechnology, agricultural, and other sectors.
The cell culture consumables and equipment market consist of sales of flasks, tubes, dishes or cryovials, serological pipettes or centrifugation tubes, bottles, cell scrapers, strainers, coverslips, and inserts. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Cell Culture Consumables And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cell culture consumables and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cell culture consumables and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell culture consumables and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Consumables; Instruments2) By Application: Vaccination; Toxicity Testing; Cancer Research; Drug Screening And Development; Recombinant Products; Stem Cell Technology; Regenerative Medicine; Other Applications
3) By End User: Industrial; Biotechnology; Agriculture; Other End Users
Subsegments:
1) By Consumables: Culture Media; Cell Culture Reagents; Serum And Supplements; Cell Culture Vials And Flasks; Culture Plates And Dishes; Pipettes And Pipette Tips2) By Instruments: Cell Culture Incubators; Bioreactors; Centrifuges; Microscopes; Cell Counters; Shakers And Stirring Systems
Companies Mentioned: Becton Dickinson and Company; Corning Inc.; Danaher Corporation; Eppendorf AG; HiMedia Laboratories Private Limited; Lonza Group AG; Merck KGAA; Promocell GmbH; Sartorius AG; Thermo Fisher Scientific Inc.; Irvine Scientific Sales Company Inc.; CellGenix GmbH; InVitria Inc.; Cytiva; Bio-Techne Corporation; GenScript Biotech Corporation; Gedeon Richter Plc.; Hetero Drugs Limited; Intas Pharmaceuticals Ltd.; LG Chem Ltd.; Lupin Limited; Bio-Rad Laboratories Inc.; Illumina Inc.; Qiagen NV; F. Hoffmann-La Roche Ltd; Norgen Biotek Corporation; Tecan Group Ltd.
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cell Culture Consumables and Equipment market report include:- Becton Dickinson and Company
- Corning Inc.
- Danaher Corporation
- Eppendorf AG
- HiMedia Laboratories Private Limited
- Lonza Group AG
- Merck KGAA
- Promocell GmbH
- Sartorius AG
- Thermo Fisher Scientific Inc.
- Irvine Scientific Sales Company Inc.
- CellGenix GmbH
- InVitria Inc.
- Cytiva
- Bio-Techne Corporation
- GenScript Biotech Corporation
- Gedeon Richter Plc.
- Hetero Drugs Limited
- Intas Pharmaceuticals Ltd.
- LG Chem Ltd.
- Lupin Limited
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- Qiagen NV
- F. Hoffmann-La Roche Ltd
- Norgen Biotek Corporation
- Tecan Group Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 16.05 Billion |
| Forecasted Market Value ( USD | $ 25.49 Billion |
| Compound Annual Growth Rate | 12.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |


